TARGET
saveGLP-1 receptor
Glucagon-like peptide-1 receptor; diabetes and obesity target.
also known as: glp-1, glp-1r, semaglutide target, tirzepatide target
🐶 often sniffed alongside
top 8- tagType 2 Diabetes3 co-mentions · 1 sources
- tagObesity2 co-mentions · 1 sources
- tagGene Therapy (AAV)2 co-mentions · 1 sources
- drugType 2 Diabetes1 co-mentions · 1 sources
- drugglucagon1 co-mentions · 1 sources
- drugRybelsus1 co-mentions · 1 sources
- companyEmory University1 co-mentions · 1 sources
- companyNew York University1 co-mentions · 1 sources
drugs
0
catalysts
0
news
888
companies
0
Top drugs
no drugs tagged with this interest yet
🐶 Top companies
no companies tagged with this interest yet
Recent catalysts
no catalysts tagged with this interest yet
Recent news
view all →- Opinion: Will Claude ever win a Nobel Prize for medicine?stat · 6h ago
- Opinion: Energy drinks’ new college sports partnerships make them more dangerous than everstat · 6h ago
- Swiss CDMOs and CROs ride a new wave of growth amid surge in global demandbiospace · 11h ago
- What it’s like to wait for the call from the Nobel Prize committeestat · 2d ago
- Kailera, Hengrui’s GLP-1/GIP candidate delivers weight, menstrual benefits to women with PMOSbiospace · 3d ago
- #EASD26: Regeneron sees a future combining its obesity drug with lipid-lowering therapyendpoints · 3d ago
- Mistrust in science and a juicy gene-editing lawsuitstat · 3d ago
- 3 takeaways from a European obesity scientific meetingbiopharma dive · 3d ago
Data sources
last refreshed 6h ago
Found something off?
comments(0)
5-min edit window · permanent after that